Clinical Trials Workshop

This 2-day workshop will provide a forum for information exchange and discussion on conceptual and practical questions through lectures and panel discussions.There will be a particular focus on the critical issues affecting sponsors and Member States as they consider the impact and changes needed to implement the regulation.

Back to Agenda

Session 1 Official Opening

Session Chair(s)

Clare Lavery, MSc

Pharmacovigilance Excellence Principal

AstraZeneca, United Kingdom

Nick Sykes, MS

Policy Advisor

EFPIA, Belgium

Co-Chairs will welcome delegates to the Workshop outlining the importance of the discussion and the aims of the two day Workshop. This will also include a keynote speech covering the role of Clinical Trials in fostering good health and supporting new technologies.

Speaker(s)

Keynote Speech

Nick Sykes, MS

EFPIA, Belgium

Policy Advisor

Clare Lavery, MSc

AstraZeneca, United Kingdom

Pharmacovigilance Excellence Principal

Key Note Speech - Regulation of the European Parliament and the Council No 536/2014 on clinical trials – responding to challenges, fostering innovation

Lidia Retkowska-Mika, LLM

Office For Registration of Med. Products, Medical Devices and Biocides, Poland

Director Legal DPT

Have an account?

Clinical Trials Workshop

Session 1 Official Opening

Session Chair(s)

Clare Lavery, MSc

Nick Sykes, MS

Speaker(s)

Keynote Speech

Clare Lavery, MSc

Key Note Speech - Regulation of the European Parliament and the Council No 536/2014 on clinical trials – responding to challenges, fostering innovation

Be informed and stay engaged.